Four Directors at Natus Medical Inc (NASDAQ:BABY) were awarded with 4,000 shares of Common Stock, $0.001 par value per share, at a price of $24.5. This award was granted pursuant to Rule 16b-3(d). Following this transaction, Director William Moore currently owns 13,660 shares at the company in a direct form, and another 143,042 shares through its different indirect holdings; Director Robert Gunst, by his part, now directly owns 50,750 securities; Director Ken Ludlum, 83,700 securities in a direct form; and Director Doris Engibous, holds directly 10,000 securities at this advanced medical equipment & technology company.

Additionally, hedge funds haven’t felt so bullish about this stock over the last reported quarter. Jay Petschek and Steven Major’s Corsair Capital Management slightly decreased its stake, and now owns 1.1 million shares, worth about $28 million, representing 2.93% of the fund’s Equity Portfolio. Ric Dillon’s Diamond Hill Capital also reduced its activity by 1%, currently holding 968,350 shares at the $804.85 million Market Cap Company, valued  at above $24 million. It was, nevertheless, Kevin Kotler’s hedge fund Broadfin Capital the one that felt most bearish about this stock, lowering its stake by 25% over the last reported quarter. It now holds 764,915 at Natus Medical Inc. (NASDAQ:BABY), worth more than $19 million, and accounting for   1.91% of its Equity Portfolio.

Disclosure: None.

Suggested Reading:

The 10 Largest Container Shipping Companies in the World

Best Warren Buffett Quotes on Money You Need to Hear